Loading…
Long-Term Outcome of Lower Extremity Bypass Surgery in Diabetic and Non-Diabetic Patients with Critical Limb-Threatening Ischaemia in Germany
To present the short- and long-term outcomes of lower extremity bypass (LEB) surgery in patients with critical limb-threatening ischaemia (CLTI), comparing diabetic (DM) and non-diabetic (non-DM) patients. Retrospective analysis of anonymised data from a nationwide health insurance company (AOK). Da...
Saved in:
Published in: | Biomedicines 2024-01, Vol.12 (1), p.38 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | To present the short- and long-term outcomes of lower extremity bypass (LEB) surgery in patients with critical limb-threatening ischaemia (CLTI), comparing diabetic (DM) and non-diabetic (non-DM) patients.
Retrospective analysis of anonymised data from a nationwide health insurance company (AOK). Data from 22,633 patients (DM:
= 7266; non-DM:
= 15,367; men:
= 14,523; women:
= 8110; mean patient age: 72.5 years), who underwent LEB from 2010 to 2015, were analysed. The cut-off date for follow-up was December 31, 2018 (mean follow-up period: 55 months).
Perioperative mortality was 10.0% for DM and 8.2% for non-DM (
< 0.001). Patients with crural/pedal bypasses (
= 8558) had a significantly higher perioperative mortality (10.3%) than those with above-the-knee (
= 7246; 5.8%;
< 0.001) and below-the-knee bypasses (
= 6829; 8.9%;
= 0.003). The 9-year survival rates in DM patients were significantly worse, at 21.5%, compared to non-DM, at 31.1% (
< 0.001). This applied to both PAD stage III (DM: 34.4%; non-DM: 45.7%;
< 0.001) and PAD stage IV (DM: 18.5%; non-DM: 25.0%;
< 0.001). Patients with crural/pedal bypasses had a significantly inferior survival rate (25.5%) compared to those with below-the-knee (27.7%;
< 0.001) and above-the-knee bypasses (31.7%;
< 0.001).
Perioperative and long-term outcomes regarding survival and major amputation rate for CLTI patients undergoing LEB are consistently worse for DM patients compared to non-DM patients. |
---|---|
ISSN: | 2227-9059 2227-9059 |
DOI: | 10.3390/biomedicines12010038 |